Omnibus IV military medical research and development
Active Awarded Last action
- Contract number
- HT001122D0030
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 1 $2,500 obligated
Award facts
- Opportunity
-
- DHA omnibus IV military medical research and development draft RFP Pre-Solicitation · HT001121R0004 · Posted Nov 13, 2020
- Combined order value
- $2,500 Current and potential, with all options
- Last date to order 44% complete
- IDV ceiling <1% used
- $10,000,000,000.00
- Award type
- Multiple award
- Who can order
- Defense agencies
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 126 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded an indefinite-delivery contract to Lovelace Biomedical Research Institute on June 20, 2022, with a $10 billion ceiling and a June 19, 2032 ultimate completion date. This is a multiple-award IDIQ for military medical research and development services with no set-aside applied.
Lovelace Biomedical Research Institute is a not-for-profit preclinical contract research organization headquartered in Albuquerque, New Mexico, specializing in Good Laboratory Practice toxicology studies, animal model development, bioanalytical services, and preclinical research across infectious disease, drug development, radiation countermeasures, and tobacco-related outcomes. The organization operates across domestic and subordinate performance locations.
The Omnibus IV IDIQ originated from a pre-solicitation posted November 13, 2020, with a due date of November 30, 2020, and was awarded June 20, 2022. The vehicle is designed to procure military medical research and development services from multiple contractors.
Recent task-order activity under this IDIQ includes a $2,500 firm fixed-price delivery order issued June 19, 2023, for military medical research and development services performed in Falls Church, Virginia, with an ultimate completion date of June 19, 2023. This order demonstrates the vehicle's use for research support across geographic locations beyond the prime's headquarters.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Military medical research and development services | Defense Health Agency | $2,500 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HT001122D0030?
HT001122D0030 was awarded to Lovelace Biomedical Research Institute by Defense Health Agency (Department of Defense) on June 20, 2022.
How much is contract HT001122D0030 worth?
Orders under HT001122D0030 have obligated $2,500. HT001122D0030's own ceiling is $10,000,000,000.
How many orders have been placed under contract HT001122D0030?
1 order has been placed under HT001122D0030, the latest on June 19, 2023.
Who can order from contract HT001122D0030?
HT001122D0030 is a multiple award indefinite delivery contract. Defense agencies can place orders on it.
Is contract HT001122D0030 part of a contract vehicle?
Yes. HT001122D0030 is part of Omnibus IV Military Medical Research And Development (OMNIBUS IV).
Was contract HT001122D0030 competed?
The extent of competition for HT001122D0030 was full and open competition. The government received 126 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV